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Hypoxic treatmentStudies in the cardiovascular research ﬁeld have demonstrated the vital roles ofmicroRNAs for proper cardiovas-
cular development and functional maintenance. The involvement of aberrant microRNA expression leading to
ontogenesis of cardiovascular diseases lends further support of the regulatory role of microRNAs in heart func-
tion. Hypoxic insult is one of the major factors that trigger downstream signal cascades which contribute to
the pathogenesis of hypoxic/ischemic-related heart diseases. Here, we report the microRNA expression proﬁle
in human cardiac-derived cells subjected to 120-h hypoxic treatment. By comparing with the normoxic control
state, we identiﬁedmicroRNAs differentially expressed in cardiac cells subjected to hypoxic challenge. MicroRNA
microarray data are available at NCBI under the GEO accession number, GSE55387.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a
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and hypoxic conditions were shown to express cardiac lineage markers including Sarcomeric1. Direct link to deposited data
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE55387.
2. Experimental design, materials and methods
2.1. Introduction
Adequate oxygen is essential for the proper function of cardiovascu-
lar tissues. Studies in various heart disease models have shown that
Sample source location Singaporetitute, Department of Medicine,
gapore, #08-01,MD6Centre for
17599, Singapore. Tel.: +65
. This is an open access article underreduced oxygen supply to the heart leads to alteration of myocardial
gene expression [1]. Hypoxia-induced microRNA signatures in various
cell lines, including tumor, vascular, and stem cells have been widely
studied [2,3]. However, there is limited information on the microRNA
proﬁle in human cardiac-derived cells. Herein, a human left ventricle-
derived cell line (HCMa) was selected for the microRNA microarray
study on the basis of two vital characteristics. Firstly, the HCMa cells
α-Actin. Secondly, the HCMa cells consistently manifested hypoxia-
induced elevated BNP/ADM responses as typically observed various
heart diseases, including heart failure and acute coronary diseases. The
goal of this work is to provide a global view of themicroRNA expression
proﬁle in human-derived cardiac cells after sub-chronic hypoxic
treatment.3. Experimental design, materials and methods
3.1. Human left ventricle derived cardiac cells
Human left ventricle-derived cardiac cells, HCMa, were obtain-
ed from ScienCell and cultured according to the manufacturer's
protocol [4]. For hypoxic challenge, cells were placed in a chamber
connected to an OXc system (BioSpheric). The chamber was
installed in a SANYO O2/CO2 incubator (MCO-18M) maintained at
5% CO2, and 37 °C. The oxygen level for hypoxic chamber was set
at 0.2% O2.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Total RNA was extracted from cells using TRIzol reagent
(Invitrogen). The RNA samples were treated with DNase I (Invitrogen)
prior to subsequent analyses. Total RNA quantity and quality were
determined by spectrophotometric (NanoDrop) and RIN analysis on
the bioanalyzer (Agilent). To obtain the global view of microRNA
expression proﬁle, microRNA microarray analysis was performed by
pooling equal amounts of total RNAs obtained from 3 RNA samples in
3 independent experiments.
3.3. MiRNAs microarray
RNA labeling and hybridization for miRCURY LNA™ Arrays were
performed according to the manufacturer's protocol (Exiqon). The mi-
croarray chips were then washed and scanned using InnoScan700 mi-
croarray scanner (Innopsys) with Mapix® Ver4.5 software (Innopsys).
3.4. Microarray data analysis
Microarray data were exported to Microsoft Excel for ﬁltering and
basic analyses. Median signal intensity readouts from each microRNA
speciﬁc probe were extracted for further comparison. The cut-off
value for signal intensity readout was set at 100, and values below
100 were excluded from subsequent analyses. For miRCURY LNA
microRNA Array v.11.0, the levels of individual microRNAs were detect-
ed using 4 probes. Student's t-test was applied to compare the differ-
ence of 4 signal intensity readouts for individual microRNAs between
experimental groups (normoxia vs. hypoxia), and microRNAs with
signiﬁcant difference between experimental groups (p b 0.05) were
included for further analysis. The average median signal intensity read-
outs for individual microRNA were normalized by the average intensity
value obtained for U6-snRNA-2. Differentially expressed miRNAs were
selected based on the relative fold change ≥1.2 and ≤ −1.2 [4].
4. Discussion
MicroRNA microarray technology has provided a high throughput
method to provide a global view of the microRNA expression proﬁle
in target tissues/cells. Nevertheless, the ability to evaluate and select
the most promising candidate entities from the large amount of
microarray data for subsequent investigations remains a major chal-
lenge. Here, we describe an analysis procedure adapted from previouspublications whereby Microsoft Excel was used for initial candidate
microRNA selection [5]. Using this method, approximately 80% of the
microRNAs of interest selected were subsequently veriﬁed using RT-
qPCR method. In a separate study, the putative regulatory effect of
microRNA-100 on natriuretic peptide receptor 3 was further demon-
strated using various biochemistry methods [4].
As revealed from the analyzed result, 145 microRNAs were found
differentially expressed in the human cardiac cell comparing the
normoxic state with hypoxic challenge ([4], GSE55387). By publishing
the details of sample preparation and the data analysis procedure, we
aim to contribute this valuable information to support further work by
the research community who may not have the resources to conduct
the upstreamwork in a similar ﬁeld of interest. The list of themicroRNA
entities provided in our work could be used for further pathway analy-
ses using free online algorithms, such as DIANA miRPath v.2.0 [6] or
commercial software such as ingenuity pathway analysis (IPA). The
regulatory effects of the microRNAs listed and their predicted target
genes would require further validation from functional studies using
in vitro and in vivo platforms.
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